A 37-year-old woman with GERD and chronic hepatitis C genotype 1a infection is preparing to begin treatment with ledipasvir/sofosbuvir. Which is the most appropriate information for the patient regarding the use of a proton-pump inhibitor during treatment with ledipasvir/sofosbuvir?